Targeted Immune-Activating Antibody Conjugates for Cancer and Infectious Disease Therapy
This technology enables precise activation of the immune system by delivering potent TLR7/8 agonists directly to diseased cells. By combining immune stimulators with antibody targeting, it enhances therapeutic impact while minimizing systemic side effects. The approach offers a safer and more effective way to treat cancer and infectious diseases by...
Published: 2/13/2026
|
Inventor(s): Lawrence Tumey, Emmanuel Olawode
Keywords(s): Technologies, XCEED
Category(s): Campus > Binghamton University, Technology Classifications > Biomedical Science and Engineering
|